Delivery Order SPE2DB20D3103-SPE2DB22FM5S7
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,590.47 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ezetimibe 10 mg tablets. This contract is not set aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical and medical products to support military healthcare...
- This federal contract award is for $2,698.87 and was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for ezetimibe 10 mg tablets, a cardiovascular medication, with a completion date of July 2, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,097.05 delivery order contract is for the supply of 90-count bottles of the prescription medication Ezetimibe 10 mg Tablet. The contract is not designated as a set-aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply the Defense Logistics Agency (DLA) with pharmaceutical products and medical supplies. The $1,344.94 delivery order contract for "EZETIMIBE 10 MG TABLET 500S" has an ultimate completion date of April 26, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,383.94 firm fixed-price delivery order is for the supply of 4,567,304 units of the pharmaceutical product Ezetimibe 10 mg tablets. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC)...
- The federal contract award is for the delivery of ezetimibe-simvastatin 10-20 mg tablets to the Defense Logistics Agency (DLA). The $1,067.10 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,050.23 firm fixed-price delivery order is for the supply of 4562437463 EZETIMIBE 10 MG TABLET 500S, a pharmaceutical product, with an ultimate completion date of October 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the provision of 4,563,337,573 units of the medication Ezetimibe 10 mg tablets. The contract has a ceiling value of $7,668.18 and a period of performance through January 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ezetimibe 10 mg tablets. The contract has a firm fixed price of $1,659.91 and a period of performance through September 26, 2024. The award is not associated with a set-aside program. As a major pharmaceutical distributor, AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of essential...
- This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,724.70, is for the delivery of EZETIMIBE-SIMVASTATIN 10-40 MG 90S medication. The award has an ultimate completion date of April 2, 2025 and was made on April 1, 2025. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM5S7Delivery Order
This federal contract award is for the delivery of Ezetimibe 10 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract has a ceiling value of $15,455.86 and is a firm fixed-price delivery order contract. There is no set-aside designation mentioned, indicating this was a full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 2/7/22 |